- Home
- BWMN vs CTMX Comparison
BWMN vs CTMX Comparison
Compare BWMN & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMN
- CTMX
- Stock Information
- Founded
- BWMN 1995
- CTMX 2008
- Country
- BWMN United States
- CTMX United States
- Employees
- BWMN N/A
- CTMX N/A
- Industry
- BWMN Military/Government/Technical
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- BWMN Consumer Discretionary
- CTMX Health Care
- Exchange
- BWMN Nasdaq
- CTMX Nasdaq
- Market Cap
- BWMN 437.5M
- CTMX 444.3M
- IPO Year
- BWMN 2021
- CTMX 2015
- Fundamental
- Price
- BWMN $36.13
- CTMX $2.40
- Analyst Decision
- BWMN Strong Buy
- CTMX Strong Buy
- Analyst Count
- BWMN 4
- CTMX 2
- Target Price
- BWMN $36.38
- CTMX $5.00
- AVG Volume (30 Days)
- BWMN 138.1K
- CTMX 1.5M
- Earning Date
- BWMN 08-06-2025
- CTMX 08-07-2025
- Dividend Yield
- BWMN N/A
- CTMX N/A
- EPS Growth
- BWMN N/A
- CTMX 128.27
- EPS
- BWMN 0.15
- CTMX 0.49
- Revenue
- BWMN $444,588,000.00
- CTMX $147,557,000.00
- Revenue This Year
- BWMN $16.66
- CTMX N/A
- Revenue Next Year
- BWMN $6.70
- CTMX N/A
- P/E Ratio
- BWMN $245.18
- CTMX $4.97
- Revenue Growth
- BWMN 21.78
- CTMX 23.81
- 52 Week Low
- BWMN $17.90
- CTMX $0.40
- 52 Week High
- BWMN $37.34
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- BWMN 80.98
- CTMX 51.91
- Support Level
- BWMN $31.28
- CTMX $2.32
- Resistance Level
- BWMN $33.28
- CTMX $2.47
- Average True Range (ATR)
- BWMN 1.26
- CTMX 0.14
- MACD
- BWMN 0.42
- CTMX -0.01
- Stochastic Oscillator
- BWMN 84.86
- CTMX 17.89
About BWMN Bowman Consulting Group Ltd.
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape and Architecture/Planning.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.